Clin Neuropathol. 2022 Nov-Dec;41(6):263-270. doi: 10.5414/NP301475.
Diffuse midline glioma (DMG) is a primary tumor of the central nervous system (CNS) with aggressive nature. It arises from midline structures in the brain and spinal cord. Recently, the presence of H3 K27M mutation is described in most cases. Extra-cranial osseous metastasis is rarely encountered.
We present an interesting case of DMG with bone metastasis at presentation in a 19-year-old male. In addition, a literature review on similar cases is presented.
DMG mostly affects children and young adults. It has a broad spectrum of phenotypes, shows diffuse growth pattern, midline location, and is frequently H3 K27M-mutant. Radiotherapy remains the mainstay of treatment that might improve overall survival. Metastasis outside the CNS remains a rare occurrence, especially at presentation, and constitute a diagnostic challenge.
Bone is one of the most common sites for metastasis of primary CNS tumors, which would severely impact prognosis. Oncologists, radiologists, and pathologists should keep an index of suspicion when encountering bone metastasis in the presence of a CNS midline tumor, so that timely diagnosis and management can be rendered.
弥漫性中线胶质瘤(DMG)是一种具有侵袭性的原发性中枢神经系统(CNS)肿瘤。它起源于大脑和脊髓的中线结构。最近,大多数病例中都描述了 H3 K27M 突变的存在。颅外骨转移很少见。
我们介绍了一例有趣的病例,一名 19 岁男性在就诊时即出现 DMG 伴骨转移。此外,还对类似病例进行了文献复习。
DMG 主要影响儿童和年轻成人。它具有广泛的表型,表现为弥漫性生长模式、中线位置,并且经常是 H3 K27M 突变型。放射治疗仍然是主要的治疗方法,可能会改善整体生存率。中枢神经系统以外的转移仍然很少见,尤其是在就诊时,这构成了诊断挑战。
骨骼是原发性中枢神经系统肿瘤转移最常见的部位之一,这将严重影响预后。当遇到中线 CNS 肿瘤伴发骨转移时,肿瘤学家、放射科医生和病理学家应保持高度警惕,以便及时做出诊断和治疗。